Sweeney, Timothy E. http://orcid.org/0000-0002-3596-1093
Perumal, Thanneer M. http://orcid.org/0000-0003-1168-8982
Henao, Ricardo http://orcid.org/0000-0003-4980-845X
Nichols, Marshall
Howrylak, Judith A.
Choi, Augustine M.
Bermejo-Martin, Jesús F.
Almansa, Raquel
Tamayo, Eduardo
Davenport, Emma E. http://orcid.org/0000-0002-8768-346X
Burnham, Katie L.
Hinds, Charles J. http://orcid.org/0000-0001-5094-8324
Knight, Julian C.
Woods, Christopher W.
Kingsmore, Stephen F.
Ginsburg, Geoffrey S.
Wong, Hector R.
Parnell, Grant P.
Tang, Benjamin
Moldawer, Lyle L.
Moore, Frederick E.
Omberg, Larsson
Khatri, Purvesh http://orcid.org/0000-0002-4143-4708
Tsalik, Ephraim L. http://orcid.org/0000-0002-6417-2042
Mangravite, Lara M. http://orcid.org/0000-0001-7841-3612
Langley, Raymond J. http://orcid.org/0000-0001-8849-9325
Article History
Received: 12 January 2017
Accepted: 18 January 2018
First Online: 15 February 2018
Competing interests
: The ‘Duke’ 18-gene score is the subject of a provisional patent filed by Duke University. The ‘Stanford’ 12-gene score is the subject of a provisional patent filed by Stanford University. T.E.S. and P.K. are co-founders of Inflammatix, Inc., which has a commercial interest in the ‘Stanford’ 12-gene score. The remaining authors declare no competing financial interests.